Mutual measures China is preparing a response to the American sanctions The commercial confrontation between the two superpowers is expanding to more and more industries. Chinese companies involved in genome research have become another cause of conflict on the eve of a possible meeting of leaders. The US Department of Homeland Security has listed BGI Genomics, MGI Tech and BGI Group as entities linked to forced labor in Xinjiang. The import of products from these companies is practically prohibited unless the suppliers prove that no forced labor was used in their production. The Chinese Ministry of Commerce has already promised to take retaliatory measures. In the summer, US authorities similarly blacklisted 43 Chinese companies. China then imposed sanctions against six American structures. Among them was the Responsible Business Alliance, a large supply chain auditing organization. A new round of sanctions is now possible. The main question is whether they will affect large American companies with significant interests in the Chinese market. Such a move would mark a considerable hardening of the position of the Chinese authorities compared to previous measures against small organizations and non-profit organizations in particular. At the same time, it seems that commercial disagreements are not yet an obstacle to the continuation of the dialogue. The expected meeting between Xi Jinping and Donald Trump at the November 18-19 APEC summit in Shenzhen appears to remain on the agenda. Nor did China's retaliatory measures in the summer disrupt the subsequent contacts between the leaders. Beijing may increase economic pressure on American structures, while at the same time trying to prevent the breakdown of high-level negotiations. And the format of the new response will show whether China is willing to expand the sanctions conflict or whether it will prefer to maintain diplomatic maneuvering space. - Your ticket to the Pacific Confusion Support us.

Mutual measures China is preparing a response to the American sanctions The commercial confrontation between the two superpowers is expanding to more and more industries. Chinese companies involved in genome research have become another cause of conflict on the eve of a possible meeting of leaders. The US Department of Homeland Security has listed BGI Genomics, MGI Tech and BGI Group as entities linked to forced labor in Xinjiang. The import of products from these companies is practically prohibited unless the suppliers prove that no forced labor was used in their production. The Chinese Ministry of Commerce has already promised to take retaliatory measures. In the summer, US authorities similarly blacklisted 43 Chinese companies. China then imposed sanctions against six American structures. Among them was the Responsible Business Alliance, a large supply chain auditing organization. A new round of sanctions is now possible. The main question is whether they will affect large American companies with significant interests in the Chinese market. Such a move would mark a considerable hardening of the position of the Chinese authorities compared to previous measures against small organizations and non-profit organizations in particular. At the same time, it seems that commercial disagreements are not yet an obstacle to the continuation of the dialogue. The expected meeting between Xi Jinping and Donald Trump at the November 18-19 APEC summit in Shenzhen appears to remain on the agenda. Nor did China's retaliatory measures in the summer disrupt the subsequent contacts between the leaders. Beijing may increase economic pressure on American structures, while at the same time trying to prevent the breakdown of high-level negotiations. And the format of the new response will show whether China is willing to expand the sanctions conflict or whether it will prefer to maintain diplomatic maneuvering space. - Your ticket to the Pacific Confusion Support us.